| For: | Miozzo SAS, John JA, Appel-da-Silva MC, Dossin IA, Tovo CV, Mattos AA. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis. World J Hepatol 2017; 9(35): 1278-1285 [PMID: 29290909 DOI: 10.4254/wjh.v9.i35.1278] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i35/1278.htm |
| Number | Citing Articles |
| 1 |
Sophie Ribiere, Marie-Anne Guillaumot, Amélie Barré, Einas Abou Ali, Maximilien Barret, Stanislas Chaussade, Romain Coriat. Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons ?. La Presse Médicale 2019; 48(5) doi: 10.1016/j.lpm.2019.02.011
|
| 2 |
Raquel de Oliveira Coberllini JACQUES, Lais da Silva MASSIGNAN, Martina Schumacher WINKLER, Rafael Sartori BALBINOT, Silvana Sartori BALBINOT, Jonathan SOLDERA. ACUTE-ON-CHRONIC LIVER FAILURE IS INDEPENDENTLY ASSOCIATED WITH LOWER SURVIVAL IN PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS. Arquivos de Gastroenterologia 2021; 58(3) doi: 10.1590/s0004-2803.202100000-58
|
| 3 |
Raj Kishor Tandon, Nakul Gupta. Clinical Profile, Microbial Spectrum, and Short-Term Outcomes in Patients with Spontaneous Bacterial Peritonitis: A Cross-Sectional Analytical Study. National Journal of Medical Research 2026; 16(01) doi: 10.55489/njmr.160120261197
|
| 4 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4) doi: 10.1111/1751-2980.13093
|
| 5 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología (English Edition) 2022; 45(1) doi: 10.1016/j.gastre.2021.02.009
|
| 6 |
Angelo A. Mattos, Denusa Wiltgen, Raquel F. Jotz, Caroline M.R. Dornelles, Matheus V. Fernandes, Ângelo Z. Mattos. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis. Annals of Hepatology 2020; 19(5) doi: 10.1016/j.aohep.2020.04.010
|
| 7 |
Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study. Alimentary Pharmacology & Therapeutics 2024; 59(8) doi: 10.1111/apt.17909
|
| 8 |
Zhen Yu Wong, Jia Hong Koh, Mark Muthiah, Benjamin Koh, Elden Yen Hng Ong, Christen En Ya Ong, Kai Qi Ou, Wen Hui Lim, Darren Jun Hao Tan, Douglas Chee, Kewin Tien Ho Siah, Yujun Wong, Apichat Kaewdech, Karn Wijarnpreecha, Anand V. Kulkarni, Benjamin Nah, Daniel Q. Huang, Mazen Noureddin, Cheng Han Ng, Margaret Teng. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis. Digestive Diseases and Sciences 2024; 69(1) doi: 10.1007/s10620-023-08150-6
|
| 9 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología 2022; 45(1) doi: 10.1016/j.gastrohep.2021.02.007
|
| 10 |
Jonathan Soldera. Beyond the Tipping Point: Advances in the Diagnosis and Management of Acute-on-Chronic Liver Failure and End-Stage Liver Disease. Diagnostics 2026; 16(10) doi: 10.3390/diagnostics16101548
|
| 11 |
Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Abdul Rehman Zia Zaidi, Ali A. Rabaan, Alyaa Elhazmi, Awad Al-Omari. Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00414-8
|
| 12 |
Lin Lin, Lijun Hou, You Deng, Tianming Zhao, Bangmao Wang, Chao Sun. Acid suppression therapy and its association with spontaneous bacterial peritonitis incidence: A systemic review and meta‐analysis. Hepatology Research 2020; 50(2) doi: 10.1111/hepr.13447
|
| 13 |
En-Qiang Qin, Guang Yang, Xin Zhang, Lei Shi, Peng Zhao, Zhe Xu, Jing-Feng Bi, Yue-Ning Zhang, Bo Tu. Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis. World Journal of Gastroenterology 2020; 26(29): 4316-4326 doi: 10.3748/wjg.v26.i29.4316
|
| 14 |
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
|
| 15 |
Amandeep Singh, Gail A. Cresci, Donald F. Kirby. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Nutrition in Clinical Practice 2018; 33(5) doi: 10.1002/ncp.10181
|
| 16 |
Shih‐Lun Teng, Che‐Han Hsu, Chia‐Chun Hsu, Jeng‐Shiann Shin, Jen‐Chieh Huang. Association of gastric acid suppressants with the development of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Advances in Digestive Medicine 2020; 7(3) doi: 10.1002/aid2.13164
|
| 17 |
Meng Zhang, Wei Liu, Xin Xu, Tao Chen, Jun-ying Qi. Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review. Current Medical Science 2022; 42(4) doi: 10.1007/s11596-022-2607-3
|
| 18 |
Moloud Balafar, Morteza Ghojazadeh, Kavous Shahsavarinia, Zahra Parsian, Saba Hamedani, Hassan Soleimanpour. Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis or Hepatic Encephalopathy in Cirrhotic Patients: A Systematic Review and Meta-analysis. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-132642
|
| 19 |
Abdel-Naser Elzouki, Nadia Neffati, Fatma A. Rasoul, Ali Abdallah, Muftah Othman, Abdelkarim Waness. Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors. GE - Portuguese Journal of Gastroenterology 2019; 26(2) doi: 10.1159/000487963
|